# Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors

> **NCT01858155** · PHASE1 · COMPLETED · sponsor: **C17 Council** · enrollment: 9 (actual)

## Conditions studied

- Relapsed Malignant Solid Tumor

## Interventions

- **DRUG:** Melatonin

## Key facts

- **NCT ID:** NCT01858155
- **Lead sponsor:** C17 Council
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2017-12
- **Final completion:** 2017-12-31
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2019-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01858155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01858155, "Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01858155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*